Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3. Zellinger B, Bodenhofer U, Englander IA, Kronberger C, et al. Breast Cancer 2022;29:274-286.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zellinger B, Bodenhofer U, Englander IA, Kronberger C, et al. Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3. Breast Cancer 2022;29:274-286.
PMID: 34865205